1PURRELLO F,RABUAZZO A M. Metabolic factors that beta-cell function and survival[J].Diabet Nutr Metab,2000,13(2):84-91.
2SIVITZ W I.Lipotoxicity and glucotoxicity in type 2 diabetes. Effects on development and progression[J].Postgrad Med,2001,109(4):55-59,63-64.
3World Health Organization: Definition Diagnosis and Classification of Diabetes Mellitus and Its Complications.Part 1.Report of a WHO Consultation: diagnosis and classification of diabetes mellitus[Z].Geneva: World Health Org,1999.
4COLWELL G A. Inflammation and diabetic vascular complications[J]. Diabetes Care,1999,22(12):1927-1928.
5NISHIO Y,KASHIWAGI A.Molecular mechanisms of endothelial dysfunction in diabetes mellitus[J].Nippon Rinsho,2001,59(12):2451-2459.
7YUDKIN J S,PANAHLOO A. The influence of improved glucose control with insulin and sulphonylureas on acute phase and endothelial markers in type Ⅱdiabetes subject[J].Diabetologia,2000,43(9):1099-1106.
1J. S. Yudkin,A. Panahloo,C. Stehouwer,J. J. Emeis,K. Bulmer,V. Mohamed-Ali,A. E. Denver. The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II Diabetic subjects[J] 2000,Diabetologia(9):1099～1106
2C. G. Schalkwijk,D. C. W. Poland,W. van Dijk,A. Kok,J. J. Emeis,A. M. Dr?ger,A. Doni,V. W. M. van Hinsbergh,C. D. A. Stehouwer. Plasma concentration of C-reactive protein is increased in Type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation[J] 1999,Diabetologia(3):351～357
3J. C. Pickup,M. A. Crook. Is Type II diabetes mellitus a disease of the innate immune system?[J] 1998,Diabetologia(10):1241～1248
4J. C. Pickup,M. B. Mattock,G. D. Chusney,D. Burt. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X[J] 1997,Diabetologia(11):1286～1292
